Stability of gadolinium chelates and their biological consequences: new data and some comments.
Port
M
M
Idee
J-M
JM
Medina
C
C
Dencausse
A
A
Corot
C
C
D000818:Animals; D003287:Contrast Media / Q000493:pharmacokinetics*; D004355:Drug Stability; D005682:Gadolinium; D019786:Gadolinium DTPA / Q000493:pharmacokinetics; D006207:Half-Life; D006571:Heterocyclic Compounds / Q000493:pharmacokinetics; D051379:Mice; D009942:Organometallic Compounds / Q000493:pharmacokinetics
D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; C062402:gadoteridol; C090600:gadobutrol; C050823:gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate; D005682:Gadolinium; D019786:Gadolinium DTPA